EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Gut microbiome, metabolome, and intestinal barrier markers correlate with disease severity in bullous pemphigoid

Ao Guo, Xiaojuan Nan, Kaidi Zhao, Shuhong Ye, Qiaoman Fei, Tian Tian, Yueshuai Zhang, Yujun Wang, Ping Liu, Xiaoli Li, Chen Tu, Yang Zhao

BMC Microbiology · 2026-11-10

DOI: 10.1186/s12866-026-05913-9 ↗

At a glance

Journal article in BMC Microbiology, published online on 2026-11-10. Written by Ao Guo and 11 co-authors. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Although gut dysbiosis and metabolic disturbances may contribute to autoimmune skin diseases, their role in bullous pemphigoid (BP) has not been established. This study aimed to characterize the gut microbiome, metabolome, and intestinal barrier markers in BP and evaluate their associations with clinical indicators. In this case-control study, 36 patients with BP and 18 healthy controls (HCs) matched for age and sex were enrolled. Full-length 16S rRNA sequencing was conducted on fecal samples from 28 patients and 18 HCs, whereas untargeted metabolomics was conducted on samples from 24 patients and 18 HCs. Serum indicators of intestinal barrier function (lipopolysaccharide [LPS], diamine oxidase [DAO], and claudin-3 [CLDN3]) were quantified in all participants. Compared with HCs, patients with BP had lower gut microbial diversity and an altered community structure characterized by increased abundances of opportunistic pathogens and decreased abundances of anti-inflammatory and short-chain fatty acid-producing bacteria. The microbial changes were associated with clinical indices, while the Escherichia coli -to- Eubacterium hallii ( E. coli / E. hallii ) ratio demonstrated high diagnostic performance (area under the receiver operating characteristic curve = 0.913). Metabolomic analysis identified 113 differential metabolites; the associated pathway alterations correlated with bacterial abundances and clinical indices. Levels of all three intestinal barrier markers were higher in BP and were associated with disease severity and inflammation. Together, the multi-omics findings demonstrated associations with BP severity. These results indicate that changes in the gut microbiome and metabolome, alongside intestinal barrier dysfunction, are associated with BP severity and support a possible role for the gut-skin axis. Further investigation is needed to determine the utility of the E. coli / E. hallii ratio as a potential noninvasive diagnostic biomarker.

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shaanxi Province

Cite

APA

Guo, A., Nan, X., Zhao, K., Ye, S., Fei, Q., Tian, T., Zhang, Y., Wang, Y., Liu, P., Li, X., Tu, C., & Zhao, Y. (2026). Gut microbiome, metabolome, and intestinal barrier markers correlate with disease severity in bullous pemphigoid. BMC Microbiology. https://doi.org/10.1186/s12866-026-05913-9

Vancouver

Guo A, Nan X, Zhao K, Ye S, Fei Q, Tian T, et al. Gut microbiome, metabolome, and intestinal barrier markers correlate with disease severity in bullous pemphigoid. BMC Microbiology. 2026. doi:10.1186/s12866-026-05913-9

BibTeX
@article{Guo2026,
  author = {Guo, Ao and Nan, Xiaojuan and Zhao, Kaidi and Ye, Shuhong and Fei, Qiaoman and Tian, Tian and Zhang, Yueshuai and Wang, Yujun and Liu, Ping and Li, Xiaoli and Tu, Chen and Zhao, Yang},
  title = {Gut microbiome, metabolome, and intestinal barrier markers correlate with disease severity in bullous pemphigoid},
  journal = {BMC Microbiology},
  year = {2026},
  doi = {10.1186/s12866-026-05913-9}
}
Start for free →